Scholarly Index
Hye‐Ryun Kang
Seoul National University Hospital; 7,459 total citations; 334 total publications; best world rank #25
Seoul National University Hospital
7,459Total citations
334Total publications
43H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Drug-Induced Adverse Reactions | Lifetime | 135 | KR 2 | 97.67 |
| Urticaria and Related Conditions | Lifetime | 531 | KR 5 | 95.86 |
| Contact Dermatitis and Allergies | Lifetime | 573 | KR 3 | 95.63 |
| IL-33, ST2, and ILC Pathways | Lifetime | 929 | KR 12 | 92.49 |
| Pharmacovigilance and Adverse Drug Reactions | Lifetime | 567 | KR 5 | 87.13 |
| Drug-Induced Adverse Reactions | 2021-2025 | 25 | KR 1 | 97.65 |
| IL-33, ST2, and ILC Pathways | 2021-2025 | 97 | KR 4 | 93.96 |
| Contact Dermatitis and Allergies | 2021-2025 | 140 | KR 2 | 92.32 |
| Asthma and respiratory diseases | 2021-2025 | 757 | KR 28 | 93.14 |
| Urticaria and Related Conditions | 2021-2025 | 387 | KR 7 | 87.14 |
| Pharmacovigilance and Adverse Drug Reactions | 2021-2025 | 259 | KR 11 | 76.48 |